National Healthcare Properties, Inc. quarterly report, Q3 FY2018

Healthcare Trust, Inc. — Form 10-Q Summary

Reporting period: Quarterly and year-to-date periods ended September 30, 2018; filed November 13, 2018. The provided filing identifies the registrant as Healthcare Trust, Inc., not National Healthcare Properties, Inc. The company is an externally managed REIT focused on U.S. medical office buildings, triple-net healthcare facilities and seniors housing operating properties. It owned 196 properties in 30 states totaling approximately 9.3 million rentable square feet.

Financial performance and position

MetricThree months ended September 30Nine months ended September 30
Total revenues$90.2 million, up 14.1%$270.6 million, up 17.9%
Operating loss$(17.6) million$(6.5) million
Net loss attributable to stockholders$(29.6) million, or $(0.33) per share$(42.5) million, or $(0.47) per share
NOI$30.9 million$104.4 million
FFO attributable to stockholders$8.4 million$37.0 million
MFFO attributable to stockholders$9.5 million$34.3 million
Cash flow from operationsNot separately provided for the quarter$38.3 million

Quarterly revenue growth was led by resident services and fee income, which increased 15.1%, and rental income, which increased 11.1%. However, property operating expenses increased 22.4%, and the company reported $17.8 million of impairment charges. Interest expense rose 42.5% to $12.6 million.

For the nine months, operating loss improved from $(15.9) million to $(6.5) million, but higher interest expense, lower other income and a tax expense resulted in net loss attributable to stockholders worsening from $(35.0) million to $(42.5) million. Total NOI increased 11.0% to $104.4 million.

  • Liquidity: Cash and cash equivalents were $52.1 million at September 30, 2018; restricted cash was $17.1 million, for total cash, cash equivalents and restricted cash of $69.2 million.
  • Debt: Total borrowings were approximately $1.02 billion at a weighted-average interest rate of 4.45%, compared with $950.2 million and 3.93% at December 31, 2017.
  • Leverage: Total debt-to-assets was approximately 43.4%. Gross mortgage notes payable were $471.2 million and credit facilities were $549.0 million.
  • Revolving facility: $189.7 million was outstanding, with $32.4 million of unused borrowing capacity; maturity was March 21, 2019.
  • Distributions: The annualized distribution rate was reduced to $0.85 per share effective March 1, 2018. Nine-month distributions totaled approximately $72.0 million, while operating cash flow was $38.3 million. Approximately 53.2% of distributions were covered by operating cash flow, with the balance funded primarily by DRIP proceeds and available cash.
  • Balance sheet: Total assets were $2.35 billion and total equity was $1.27 billion at September 30, 2018. Accumulated deficit was $774.4 million.

Material changes versus the prior comparable period

  • Revenue increased $41.1 million for the nine months, primarily from SHOP growth and acquisitions, while property operating expenses increased $30.7 million.
  • SHOP revenue increased 22.1% to $178.7 million, primarily due to 18 properties transitioned from the triple-net segment and other acquisitions. SHOP NOI increased 9.5% to $46.4 million.
  • MOB NOI increased 18.1% to $51.1 million, mainly from 2018 acquisitions; same-store MOB NOI was essentially flat.
  • Triple-net healthcare NOI decreased 17.5% to $6.9 million, affected by tenant defaults, lower rents and property transitions to SHOP.
  • Interest expense increased $15.1 million for the nine months because of higher debt balances and interest rates. New financing included a $118.7 million multi-property CMBS loan and additional Fannie Mae facility borrowings.
  • The company acquired 11 properties during the nine months, primarily MOBs, for an aggregate contract purchase price of $66.7 million, and funded $73.5 million of real estate investments.
  • Common shares outstanding increased to 91.6 million from 91.0 million at December 31, 2017, reflecting 1.4 million DRIP shares, partially offset by 529,871 repurchased shares.
  • The board approved an estimated per-share NAV of $20.25 as of December 31, 2017, down from $21.45 as of December 31, 2016.

Guidance, outlook, risks and unusual items

  • No formal earnings or financial guidance was provided. Management expects to refinance or extend 2019 mortgage maturities and refinance the revolving credit facility before its March 2019 maturity.
  • The company had three pending agreements to acquire seven MOBs for an aggregate contract purchase price of $84.5 million. Completion was subject to conditions and was not assured.
  • Eight Missouri skilled nursing properties and six New York MOBs were classified as held for sale. Subsequent to quarter-end, the Missouri sale agreement was amended to a $27.5 million purchase price, with a $4.0 million non-refundable extension and waiver fee. The company recognized approximately $10.4 million of impairment on the Missouri properties and $6.2 million on the New York MOBs.
  • LaSalle tenants were in default on four Texas properties and owed $2.9 million; the receivable and related income were fully reserved. The company incurred $3.6 million of related bad debt expense for the nine months.
  • NuVista tenants at two Florida properties owed $8.0 million and were fully reserved. Related bad debt expense was $5.4 million for the nine months. Litigation was commenced regarding a Wellington property transition and potential tenant replacement.
  • The Jupiter, Florida development remained delayed and had not generated income because a final certificate of occupancy had not been obtained. The company had funded $88.7 million, including $6.7 million above its stated construction funding commitment, and did not expect the original Palm-related tenant to occupy the facility.
  • Interest-rate exposure remains significant because portions of the debt are variable rate. The company uses swaps and caps; derivative assets were $9.3 million at quarter-end.
  • Management disclosed that distributions have historically exceeded operating cash flow and may require DRIP proceeds, borrowings, asset-sale proceeds or available cash. Distributions may be reduced or suspended.
  • The company remains dependent on its external advisor and related parties, which received $24.0 million of operating fees and reimbursements during the nine months.
  • The company reported effective disclosure controls, no material changes in internal control over financial reporting and no material pending legal or regulatory proceedings. It also reported no material off-balance-sheet arrangements.

Most important facts for investors to verify

  • Confirm that the intended issuer is Healthcare Trust, Inc.; the request metadata names a different company.
  • Assess refinancing risk for the $38.3 million of 2019 scheduled mortgage maturities and the $189.7 million revolving facility maturing in March 2019.
  • Evaluate distribution sustainability given $38.3 million of operating cash flow versus approximately $72.0 million of distributions during the first nine months.
  • Monitor whether the Missouri and New York dispositions close at the stated prices and whether debt repayment and reinvestment proceeds are accretive.
  • Track recovery, litigation and tenant replacement efforts involving LaSalle, NuVista and Palm, including the $2.9 million and $8.0 million reserved receivables.
  • Review the effect of higher interest rates and the company’s variable-rate debt exposure on future interest expense and cash available for distributions.
  • Verify pending MOB acquisitions, available borrowing capacity and compliance with the $30.0 million minimum unrestricted cash covenant.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.